Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
Customers have known for months that the Dexcom G7 continuous glucose monitoring sensor had problems. Now, the company is ...
Zacks Investment Research on MSN
Dexcom reports positive CONNECT data for non-insulin diabetes
DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...
MyLife Diabetes Care, CamDiab and Dexcom today announced the integration of the G7 continuous glucose monitor (CGM) into the ...
DexCom Inc. DXCM stock is trading higher on Monday after the diabetes management company reported positive results from its ...
Glucose monitoring specialist Dexcom announced it received FDA clearance for its G7 15 Day continuous glucose monitoring (CGM) system for people 18 and older with type 1, type 2 and gestational ...
Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks.
DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results